EdwardSSchulmanMD

PubMed

• 35 citations
  Primary immune deficiency diseases as unrecognized causes of chronic respiratory disease.
  Melvin Berger, Bob Geng, D. William Cameron, Ladonna M. Murphy, Edward S. Schulman
  Respiratory Medicine. 2017-11-01
• 375 citations
  A highly sensitive fluorescent micro-assay of H2O2 release from activated human leukocytes using a dihydroxyphenoxazine derivative.
  J.G Mohanty, Jonathan S. Jaffe, Edward S Schulman, Donald G. Raible
  Journal of Immunological Methods. 1997-03-28
• 548 citations
  Diagnosis and Management of Cough Executive Summary: ACCP Evidence-Based Clinical Practice Guidelines
  Richard S. Irwin, Michael H. Baumann, Donald C. Bolser, Louis-Philippe Boulet, Sidney S. Braman
  Chest. 2006-01-01

Journal Articles

• Histamine releasing factors from culture human monocyte macrophages.  
  Schulman ES, McGettigan MC, Post TJ, Vigerman RJ, Shapiro SS, J Immunol
• Rationale for Specific Allergen Testing of Asthma Patients in the Clinical Pulmonary Office Setting, Submitted.  
  Schulman ES and Pohlig, C, Chest
• Algorithm: Secondary Prevention of Ischemic Stroke.  
  Sherman MS, Schulman ES, Postgraduate Medicine
• Algorithm: Acute Stroke.  
  Sherman MS, Schulman ES, Postgraduate Medicine
• Long-Term Cultivation and Functional Responsiveness of Human Lung Mast Cells.  
  Schulman ES, Mohanty JG, J Allergy Clin Immunol
• ACCP evidence-based clinical rapctice guidelines.  
  Irwin RS, Baumann MH, Bolser DC, Boulet LP, Braman SS, Brightling CE, Brown, KK, Canning BJ, Chang AB, Dicpinigaitis PV, Eccles R, Glomb WB, Goldstein LB, Graham LM, H..., Chest
• ATP causes neurogenic bronchoconstriction in the dog.  
  Katchanov G, Xu J, Schulman ES, Pelleg A, Drug Development Research
• Inhibition of lipid mediator biosynthesis in human inflammatory cells by BIRM 270.  
  Parks TP, Hoffman AF, Homon CA, Graham AG, Lazer ES, Chilton FH, Borgeat P, Raible D, Schulman ES, Bass DA, et al, Eosin Search, Agents & Actions (Suppl)
• IgE-mediated interleukin-5 generation by human lung fragments and mast cells.  
  Jaffe JS, Glaum MC, Raible DG, Post TJ, Dimitry E, Govindarao D, Wang Y, Schulman ES, Am J Resp Cell Mol Biol
• Effects of 6 weeks of therapy with oral doses of ICI 204,219, a leukotriene D4 receptor antagonist, in subjects with bronchial asthma.  
  42. Spector SL, Smith LJ, Glass M, Schulman ES (Member of ACCOLATETM Asthma Trialists Group), Am J Respir Crit Care Med
• The role of 5 lipoxygenase products in preclinical models of asthma.  
  Wegner CD, Gundel RH, Abraham WM, Schulman ES, Kontny MJ, Lazer ES, Homon CA, Graham AG, Torcellini CA, Clarke CG, Jager P, Wolyniec WW, Letts LG, Farina PR, J Allergy Clin Immunol
• Raised histamine concentrations in chronic cholestatic liver disease.  
  Gittlen SD, Schulman ES, Maddrey WC, Gut
• Malignant mesothelioma: Diffuse contralateral pulmonary metastases, an unusual radiographic presentation.  
  Uri A, Schulman ES, Steiner RM, Scott R, Rose LJ, Chest
• Anaphylactic release of thromboxane A21, prostaglandin D2, and prostacyclin from human lung parenchyma.  
  Schulman ES, Newball HH, Demers LM, Fitzpatrick FA, Adkinson NF, Jr, Am Rev Respir Dis
• Low density lipoprotein (LDL) inhibits histamine release from human mast cells.  
  Schulman ES, Quinn TJ, Post TJ, O'Donnell P, Rodriguez A, Gonen B, Biochem Biophys Res Comm
• Hypoxemia with normal chest roentgenogram due to Pneumocystis carinii pneumonia. Diagnostic errors due to low suspicion of AIDS.  
  Israel HL, Gottlieb JA, Schulman ES, Chest
• Very low density lipoproteins trigger human basophil histamine release.  
  Gonen B, O'Donnell P, Post TJ, Quinn T, Schulman ES, Biochemica et Biophysica Acta
• The role of mast cell derived mediators in airway hyper responsiveness.  
  Schulman ES, Chest
• Human lung macrophage derived histamine release activity is due to an IgE binding factor(s).  
  Liu MC, Proud D, Lichtenstein LM, MacGlashan DW, Jr, Schleimer RP, Adkinson NF, Jr, Kagey Sobotka A, Schulman ES, Plaut M, J Immunol
• Purified human mast cells and basophils release human elastase and cathepsin G by an IgE mediated mechanism.  
  Meir HL, Heck LW, Schulman ES, MacGlashan DW, Jr, Int Arch Allergy Appl Immunol
• IgE mediated triggering signals for mediator release from human lung mast cells.  
  Ishizaka T, Conrad DH, Schulman ES, Sterk AB, Ishizaka K, Fed Proc
• Lipid bodies: Cytoplasmic organelles important to arachidonate metabolism in macrophages and mast cells.  
  Dvorak AM, Dvorak HF, Peters SP, Schulman ES, MacGlashan DW, Jr, Pyne K, Harvey VS, Galli SJ, Lichtenstein LM, J Immunol
• Heterogeneity of human lung mast cells.  
  Schulman ES, Kagey Sobotka A, MacGlashan DW, Jr, Adkinson NF, Jr, Peters SP, Schleimer RP, Lichtenstein LM, J Immunol
• Basophil and mast cell degranulation. Ultrastructural analysis or mechanisms of mediator release.  
  Dvorak AM, Galli SJ, Lichtenstein LM, Schulman ES, Dvorak HF, Fed Proc
• Comparative studies of human basophils and mast cells.  
  MacGlashan DW, Schleimer RP, Peters SP, Schulman ES, Adams GK, III, Sobotka AK, Newball HH, Lichtenstein LM, Fed Proc
• Join now to see all

Books/Book Chapters

• The Pocket Doctor. 
  Sherman MS, Schulman ESEducational Communications
• The Instant Exam Review for USMLE STEP III. 
  Chapter: Diseases and disorders of the respiratory system 
  Page 297 - 316Sherman MS, Schulman ESEditors: J.S. Goldberg.Appleton and Lange
• Pulmonary Diseases and Disorders, vol. 1, 3rd ed. 
  Chapter: Mast cells and eosinophils 
  Page 289 - 301Schulman ES, Raible DGEditors: A.P. Fishman.McGraw-HillEdition 3,
• Asthma and Rhinitis. 
  Chapter: Mechanisms of mast cell activation 
  Page 296 - 310Schulman ES, Yassin R, Peters SEditors: William Busse, Stephen Holgate.Blackwell Science
• The Instant Exam Review for USMLE STEP I. 
  Chapter: Pulmonary Medicine 
  Sherman MS, Schulman ESEditors: J.S. Goldberg.William and Wilkins
• The Instant Exam Review for USMLE STEP I 
  Chapter: Pulmonary Medicine 
  Sherman MS, Schulman ESEditors: J.S. Goldberg.Williams & Wilkins
• USMLE STEP III Outline Review. 
  Chapter: Pulmonary Medicine 
  Page 491 - 525Sherman MS, Schulman ESEditors: J.S. Goldberg.Appleton and Lange
• USMLE STEP III Outline Review. 
  Chapter: Pulmonary Medicine 
  Sherman MS, Schulman ESEditors: J.S. Goldberg.Appleton and Lange
• Pulmonary Diseases and Disorders. 
  Chapter: Mast Cells and Eosinophils 
  Page 309 - 329Schulman ES, Sporn, PHSEditors: Fishman AP, Elias JA, Fishman JA, Grippi MA and Senior RPAI.McGraw Hill, New York
• The Pocket Doctor. 
  Sherman MS, Schulman ESEducational Communications
• The Pocket Doctor. 
  Sherman MS, Schulman ESEducational Communications
• The Instant Exam Review of USMLE TEP III. 
  Chapter: Pulmonary medicine 
  Page 297 - 316Sherman MS, Schulman ESEditors: J.S. Goldberg.Appleton and LangeEdition 2,
• The Pocket Doctor. 
  Sherman MS, Schulman ESPocket Doctor Press, WilmingtonEdition 4,
• The Pocket Doctor. 
  Chapter: Management of Acute Pulmonary Embolism 
  Schulman, ESEditors: Sherman, MS and Schulman, ES.Educational Communications, Mt. Kisko, NYEdition 1,
• The Pocket Doctor. 
  Chapter: Pleural Effusions 
  Schulman, ESEditors: Sherman, MS and Schulman, ES.Educational Communications, Mt. Kisko, NYEdition 1,
• The Pocket Doctor. 
  Chapter: Management of Acute Pulmonary Embolism 
  Schulman, ESEditors: Sherman, MS and Schulman, ES.Educational Communications, Mt. Kisko, NYEdition 2,
• The Pocket Doctor. 
  Chapter: Pleural Effusions 
  Schulman, ESEditors: Sherman, MS and Schulman, ES.Educational Communications, Mt. Kisko, NYEdition 2,
• The Pocket Doctor. 
  Chapter: Smoking Cessation 
  Schulman, ESEditors: Sherman, MS and Schulman, ES.Educational Communications, Mt. Kisko, NYEdition 2,
• The Pocket Doctor. 
  Chapter: Management of Acute Pulmonary Embolism 
  Schulman, ESEditors: Sherman, MS and Schulman, ES.Educational Communications, Mt. Kisko, NYEdition 2,
• The Pocket Doctor. 
  Chapter: Pleural Effusions 
  Schulman, ESEditors: Sherman, MS and Schulman, ES.Educational Communications, Mt. Kisko, NYEdition 2,
• The Pocket Doctor. 
  Chapter: Smoking Cessation 
  Schulman, ESEditors: Sherman, MS and Schulman, ES.Educational Communications, Mt. Kisko, NYEdition 2,
• Prostaglandins, Leukotrienes and Lipoxins. 
  Chapter: Lipid bodies:Widely distributed cytoplasmic structures that represent preferential non membrane repositories of exogenous 3H arachidonic acid incorporated by mast cells, macrophages, and other cell.. 
  Page 221 - 239Galli SJ, Dvorak AM, Peters SP, Schulman ES, MacGlashan DW, Jr, Isomura T, Pyne K, Harvey VS, Hammel I, Lichtenstein LM, Dvorak HFEditors: Bailey JM.Plenum, New York
• Immunopharmacology of the Lung. 
  Chapter: Anaphylactic release of arachidonic acid metabolites from the lung 
  Page 55 - 72Adkinson NF, Jr, Schulman ES, Newball HHEditors: H. Newball.Marcel Dekker Inc, New York
• Advances in Immunopharmacology. 
  Chapter: Lipooxygenase products of arachidonic acid: Their role in inflammatory events mediated by human basophils and mast cells 
  Page 617 - 622Peters SP, Schleimer RP, MacGlashan DW, Jr, Schulman ES, Kagey Sobotka A, Adams GK, III, Lichtenstein LMEditors: J.W. Hadden, et al.Pergamon Press, Oxford
• Proceedings of the Second John Jacob Abel Symposium. 
  Chapter: The role of lipooxygenase products of arachidonic acid in inflammatory events mediated by human basophils and mast cells 
  Page 83 - 97Peters SP, Schleimer RP, Kagey Sobotka A, Schulman ES, MacGlashan DW, Jr, Adams GK, III, Lichtenstein LMAcademic Press, New York
• Join now to see all

Abstracts/Posters

• Differential effects of dexamethasone on human lung mast cells: Cytokine modulation vs. histamine release.
  Glaum MC, Jaffe JS, Raible DG, Wang Y, Post TJ, Schulman ES, J Allergy Clin Immunol
• Effects of ATP on human eosinophils and lung mast cells.
  Schulman, ES, Mohanty, JG, Raible, DG, Pelleg, A, Drug Development research
• Pharmacology and signal-transduction pathways of ATP-induced activation of human eosinophils.
  Raible DG, Mohanty JG, McDermott LJ, Wang Y, Pelleg A, Schulman ES, Am J Resp Crit Care Med
• Elevated stem cell factor and alpha-protryptase levels in uremia.
  Brezin AL, Brezin JH, Raible DG, Schwartz LB, Schulman ES, J Allergy Clin Immunol
• A2a-adenosine receptor mediates the effect of adenosine on anti-IgE-induced histamine release from human basophils.
  Goulatia A, Raible DG, Pelleg A, Schulman ES, J Allergy Clin Immunol
• ATP modulates anti-IgE-induced release of histamine from human lung mast cells.
  Schulman ES, Glaum M, Post T, Wang Y, Pelleg A, J Allergy Clin Immunol
• TGF-B mRNA and protein generation by purified human lung mast cells.
  Glaum MC, Jaffe JS, Wang Y, Post TJ, Raible DG, Schulman ES, Am J Resp Crit Care Med
• Fibronectin-induced hydrogen peroxide release from eosinophils (EOS): The detection method matters.
  Raible DG, Mohanty JG, Jaffe JS, Stella HJ, Sprenkle BE, Glaum M, Schulman ES, Am J Resp Crit Care Med
• Mechanisms of ATP=s enhancement of histamine release from human lung mast cells (HLMC).
  Schulman ES, Glaum M, Post TJ, Wang Y, Yassin R, Pelleg A, Am J Resp rit Care Med
• ATP-triggered reflex bronchoconstriction. Sixth International Symposium on Adenosine and Adenine Nucleotides.
  Katchanov G., Xu J, Schulman ES, Pelleg A, Drug Development Research
• P2- purinoceptor-mediated enhancement of anti-IgE stimulated human lung mast cell histamine release. Sixth International Symposium on Adenosine and Adenine Nucleotides.
  Schulman ES, Glaum M, Post T, Wang Y, Raible D, Mohanty J, Pelleg A, Drug Development Research
• Inducible TGF-ß production by human lung mast cells.
  Glaum MC, Jaffe JS, Wang Y, Post TJ, Schulman ES, Clin Res
• Long-Term Cultivation of Human Lung Mast Cells.
  Schulman, ES, Mohanty, JG, J. Allergy Clin. Immunol
• ATP modulates histamine release from human lung mast cells.
  Schulman ES, Post T, Pelleg A, Am J Resp Crit Care Med
• Propranolol enhances histamine and interleukin-5 generation from anti-IgE challenged human lung fragments: Evidence for inverse agonist effect.
  Remy FJ, Jaffe JS, Raible DG, Post TJ, Wang Y, Glaum M, Schulman ES, J Allergy Clin Immunol
• Isoproterenol and salmeterol-induced attenuation of interleukin-5 mRNA and protein from anti-IgE challenged human lung fragments.
  Remy FJ, Dimitry EA, Jaffe JS, Raible DG, Post TJ, Glaum M, Wang Y, Schulman ES, Am J Resp Crit Care Med
• IgE dependent expression of interleukin 5 mRNA in human lung is modulated by dexamethasone.
  Glaum MC, Gillespie DH, Schulman ES, J Allergy Clin Immunol
• IgE dependent secretion of IL 5 by lung fragments and human lung mast cells.
  Schulman ES, J Allergy Clin Immunol
• Inhibition of human eosinophil activation by secretory eukocyte protease inhibitor.
  Guy C, Scoopo FJ, Fayvilevich Y, Schulman ES, Raible DG, Am Rev Resp Dis
• B adrenergic agonist induced attenuation of interleukin 5 mRNA and protein from anti IgE challenged human lung fragments.
  Dimitry EA, Jaffe JS, Post TJ, Glaum M, Wang Y, Gillespie D, Schulman ES, Am J Resp Crit Care Med
• Interleukin 5 is expressed at a transcriptional level in human lung.
  Glaum MC, Gillespie DH, Schulman ES, J Immunol
• Activation of human lung mast cells induces early expression of IL 5 mRNA, but not IL 3, IL 4 and GM CSF.
  Jaffe JS, Schulman ES, J Immunol
• Effects of human recombinant c kit receptor ligand, rhSCF, on human lung mast cell heterogeneity.
  Bridges M, Schulman ES, Vallorosi C, Post TJ, Clin Res
• Differential Effects of Albuterol Stereoisomers on Human Lung Mast Cell Mediator Release.
  E.S. Schulman, H. Nishi, A. Pelleg, Am J Respir Crit Care Med
• Differential Effects of Short- and Long-Term Exposure to Interleukin-4 on Human Lung Mast Cell IgE-Mediated Histamine Release.
  Schulman ES, Am J Respir Crit Care Med
• Join now to see all

Lectures

• Compelling Outcomes in Pulmonary Disease: Exercise Studies in COPD. 
  Hyatt Regency, Philadelphia, PA
• IgE Mediated Asthma – A Problem Based Learning Approach. 
  New York
• Asthma – A Problem Based Learning Approach. 
  Charlotte, NC
• Sepracor Scientific Steering Committee. 
  Chicago, IL
• Xolair Disease Modification Advisory Board. 
  Chicago, IL
• Asthma Update 2007. 
  Drexel University College of Medicine, Clinical Update Symposium, Aspen, CO
• Sepracor Scientific Research Forum. 
  Conference on Beta, Agonists Naples, Florida
• Introduction to Pharmacology of Antiallergic/Asthmatic Drugs. 
  City College of New York, Sophie Davis School of Medicine, New York, NY
• Innate Immunity and Mast Cells. 
  Puerto Vallarta, Mexico
• Teach the Teacher: A Problem Based Learning Approach. 
  Chicago, IL
• Update in the Treatment of Asthma. 
  Deborah Heart and Lung Center, Brown Mills, NJ
• Long Acting Beta Agonists: Safety. 
  New York, NY
• Are Mast Cells Still Important? & The Role of Adenosine and Adenine Nucleotides in Asthma and Cough. 
  University of Virginia, Charlottesville, VA
• Asthma Progression: Pathology versus Clinical Cause- Therapeutic Implications. 
  Falls Church, VA
• Asthma Progression: Therapeutic Implications. 
  Cleveland, OH
• Interaction of Mast Cells with the Innate Immune Systems. 
  Annual Meeting, Anaheim CA
• Cysteinyl Leukotrienes: Important Mediators in the Pathogenesis of Allergic Rhinitis. 
  Charleston, SC
• New Concepts in Asthma; Pathogenesis and Treatment. 
  UMDNJ (2005); Abington, PA (2006)
• Asthma Progression. 
  Asthma and Immunology New York, NY
• Clinical Considerations for Managing IgE-Mediated Asthma. 
  Access Communications Short Hills, NJ
• New Concepts in Asthma: Pathogenesis and Treatment. 
  North Shore University Hospital Manhasset, NY
• Managing Airway Disease in Asthma and COPD: A Comparative Approach. 
  San Diego, CA
• Asthma – New Advances, Understanding and Treatment. 
  Our Lady of Lourdes Medical Center Camden, NJ
• Latest in Asthma Treatments. 
  Holy Redeemer Hospital and Medical Center
• New Management Strategies for Asthma. 
  Inter-Continental Hotel, Montreal, Canada
• Join now to see all